Cambridge Investment Research Advisors Inc. Trims Stock Position in Crocs, Inc. (NASDAQ:CROX)

Cambridge Investment Research Advisors Inc. decreased its position in Crocs, Inc. (NASDAQ:CROX – Get Rating) by 29.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,469 shares of the textile maker’s stock after selling 1,886 shares during the quarter. Cambridge Investment Research Advisors Inc.’s holdings in Crocs were worth $485,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Marshall Wace LLP grew its stake in shares of Crocs by 295.6% during the third quarter. Marshall Wace LLP now owns 1,717,628 shares of the textile maker’s stock worth $117,936,000 after purchasing an additional 1,283,455 shares in the last quarter. Assenagon Asset Management S.A. acquired a new position in shares of Crocs during the fourth quarter worth $62,045,000. Portolan Capital Management LLC grew its stake in shares of Crocs by 251.7% during the third quarter. Portolan Capital Management LLC now owns 403,754 shares of the textile maker’s stock worth $27,722,000 after purchasing an additional 288,942 shares in the last quarter. BlackRock Inc. grew its stake in shares of Crocs by 3.9% during the first quarter. BlackRock Inc. now owns 6,646,713 shares of the textile maker’s stock worth $507,811,000 after purchasing an additional 247,828 shares in the last quarter. Finally, Lord Abbett & CO. LLC grew its stake in shares of Crocs by 58.7% during the third quarter. Lord Abbett & CO. LLC now owns 621,873 shares of the textile maker’s stock worth $42,698,000 after purchasing an additional 230,120 shares in the last quarter. Hedge funds and other institutional investors own 84.95% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have issued reports on the stock. B. Riley upped their price objective on shares of Crocs from $157.00 to $159.00 in a research note on Friday, April 28th. Robert W. Baird upped their price objective on shares of Crocs from $175.00 to $185.00 in a research note on Friday, April 28th. Stifel Nicolaus upped their price objective on shares of Crocs from $133.00 to $150.00 and gave the company a “hold” rating in a research note on Friday, April 21st. StockNews.com assumed coverage on shares of Crocs in a research note on Thursday, May 18th. They issued a “hold” rating for the company. Finally, TheStreet upgraded shares of Crocs from a “c+” rating to a “b” rating in a research note on Monday, January 30th. Five equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, Crocs presently has a consensus rating of “Moderate Buy” and an average target price of $158.00.

Crocs Trading Up 0.2 %

Shares of Crocs stock opened at $104.32 on Friday. The company has a debt-to-equity ratio of 2.32, a current ratio of 1.76 and a quick ratio of 1.01. Crocs, Inc. has a 1 year low of $46.08 and a 1 year high of $151.32. The company has a market capitalization of $6.47 billion, a P/E ratio of 10.55, a P/E/G ratio of 0.61 and a beta of 1.94. The business has a 50 day moving average price of $123.34 and a 200 day moving average price of $115.08.

Crocs (NASDAQ:CROX – Get Rating) last issued its quarterly earnings data on Thursday, April 27th. The textile maker reported $2.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.15 by $0.46. Crocs had a return on equity of 98.41% and a net margin of 16.33%. The firm had revenue of $884.20 million during the quarter, compared to the consensus estimate of $857.76 million. During the same period in the previous year, the firm posted $2.05 EPS. The company’s quarterly revenue was up 33.9% compared to the same quarter last year. Sell-side analysts anticipate that Crocs, Inc. will post 11.53 EPS for the current fiscal year.

Insiders Place Their Bets

In other Crocs news, CEO Andrew Rees sold 9,164 shares of the business’s stock in a transaction on Monday, April 17th. The shares were sold at an average price of $140.02, for a total value of $1,283,143.28. Following the transaction, the chief executive officer now owns 110,584 shares in the company, valued at approximately $15,483,971.68. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, Director Thomas J. Smach acquired 3,000 shares of the business’s stock in a transaction on Monday, March 13th. The shares were purchased at an average price of $113.15 per share, for a total transaction of $339,450.00. Following the acquisition, the director now directly owns 3,000 shares of the company’s stock, valued at approximately $339,450. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Andrew Rees sold 9,164 shares of the business’s stock in a transaction on Monday, April 17th. The stock was sold at an average price of $140.02, for a total transaction of $1,283,143.28. Following the completion of the transaction, the chief executive officer now owns 110,584 shares in the company, valued at approximately $15,483,971.68. The disclosure for this sale can be found here. 2.71% of the stock is currently owned by company insiders.

About Crocs

(Get Rating)

Crocs, Inc engages in the design, development, manufacturing, worldwide marketing, sale, and distribution of casual footwear and accessories for men, women, and children. It operates through the following segments: North America, Asia Pacific, Europe, Middle East, Africa, and Latin America (EMEALA), and HEYDUDE Brand.